Tag Archives: ViiV Healthcare

July, 2018

November, 2017

June, 2016

January, 2016

  • 8 January

    Viiv and Janssen Collaborate to Develop HIV Maintenance Therapy

    CORK, Ireland, January 7, 2016 /PRNewswire/ — Results from ongoing phase IIb Week 32 study show that if successfully developed and approved, people living with HIV could potentially maintain viral suppression Janssen Sciences Ireland UC (Janssen), today formalized its collaboration with ViiV Healthcare on phase III development and commercialization of …

December, 2015

  • 18 December

    GSK to Pay up to $1.5 Billion for Next Generation of HIV Treatments

    GlaxoSmithKline plc (LSE: GSK) today announced that its global HIV business, ViiV Healthcare, has reached two separate agreements with Bristol-Myers Squibb, to acquire its late-stage HIV R&D assets; and to acquire Bristol-Myers Squibb’s portfolio of preclinical and discovery stage HIV research assets. Under the terms agreed in the two transactions, …

November, 2015